Abstract:In Magnetic Drug Targeting (MDT), an alternative and highly efficient technique to traditional drug delivery methods, therapeutic agents labeled with magnetic particles are transported to a target region using an external magnetic field. A high concentration of agents in the target tissue and their non-dispersion in the body increases treatment efficiency. In this study, targeted delivery of endothelial cells containing magnetic particles in a healthy and stenosed patient-specific carotid artery was studied. The Eulerian-Lagrangian approach was adapted to track the motion of particles and solve fluid equations. The effect of many internal parameters such as plaque morphology (occlusion percentage and the chord length of stenosis) and external parameters such as the strength and the position of the magnetic source, injection time, and the mass of magnetic particles inside each cell on the capture efficiency (CE) of cells was investigated. Results reveal that increasing the mass of magnetic particles in each cell and magnetic field strength enhances the capture efficiency of cells in the target region. Also, shifting the magnetic source location from position 1 (before the carotid sinus) to position 3 (after the carotid sinus) can increase and decrease the number of absorbed cells in the target region and CCA, respectively, both of which are desirable. Investigation of the injection time shows that the CE of cells when injecting in the systole and diastole is approximately the same as their CE when injected in a whole cardiac cycle. For a stenosed carotid artery, the percentage of occlusion is directly related to the CE of cells in the target region. Also, the chord length of stenosis has a direct and inverse relationship with the number of absorbed cells on the plaque surface and in the target region, respectively. Therefore, magnetic particles with higher magnetism or stronger magnetic fields are recommended for the stenosed carotid artery with a more severe occlusion percentage or a longer chord length.

Advances in smart delivery of magnetic field-targeted drugs in cardiovascular diseases

Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?

Ultrasound And Magnetic Responsive Drug Delivery Systems For Cardiovascular Application

Magnetic drug delivery systems

Nanomedicine in cardiology: Precision drug delivery for enhanced patient outcomes

Targeted delivery of therapeutic agents in a healthy and stenosed patient-specific carotid artery using an external magnetic field

Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases

Research progress of magnetic targeted therapy

Progress on Physical Field‐Regulated Micro/Nanomotors for Cardiovascular and Cerebrovascular Disease Treatment

Two-Phase Biofluid Flow Model for Magnetic Drug Targeting

Specific, Non-Invasive, and Magnetically Directed Targeting of Magnetic Erythrocytes in Blood Vessels of Mice

Enhancing capture efficiency of drug-carrier particles in the carotid sinus by utilizing a combination of magnetic fields: A numerical approach

Numerical Studies on Magnetic Driven Targeted Drug Delivery in Human Vasculature

Analysis and Design of a New Hybrid Array for Magnetic Drug Targeting

Magnetically Controlled Strategies for Enhanced Tissue Vascularization

Magnetic Nanoparticle Drug Targeting to Patient-Specific Atherosclerosis: Effects of Magnetic Field Intensity and Configuration

An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery

The Effect of Nonuniform Magnetic Targeting of Intracoronary-Delivering Mesenchymal Stem Cells on Coronary Embolisation.

Haptic-Based Manipulation Scheme of Magnetic Nanoparticles in a Multi-Branch Blood Vessel for Targeted Drug Delivery

Multifunctional Magnetic Nanomedicine Drug Delivery and Imaging‐Based Diagnostic Systems

Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders